RELEASE: The number of promising young scientists is increasing, Zentiva has awarded them for the fifth time

(Information sent by the signatory company).

RELEASE: The number of promising young scientists is increasing, Zentiva has awarded them for the fifth time

(Information sent by the signatory company)

PRAGUE, March 1, 2023 /PRNewswire/ -- Talented young scientists from the Center for Applied Pharmaceutical Research (The Parc), founded by Zentiva in cooperation with leading Czech universities, were honored with the annual Parc Awards. The ceremony was held under the auspices of Prof. Msgr. Jaroslav Miller, MA, Ph.D., Deputy Minister of Education, Youth and Sports of the Czech Republic. The students and their supervisors selected the best projects in the field of applied medicine research and development. The Parc has grown over the last year, and currently 32 students are studying there for an industrial doctorate. In 2022, they published 22 scientific articles and presented 39 communications in congresses.

The Parc PhD students received The Parc Awards in two categories. In the Parc Student Award category, Thao Tranová won with the project "Orodispersible tablets prepared from spray-dried materials". The second prize for students went to Martin Krov for his project "High-throughput development and continuous manufacturing of SMEDD systems", and the third prize went to Elizaveta Mutylo for her work "Programmable drug release from multi-unit dosage forms". ". In the second category, the Parc Supervisor Award, Ondřej Navrátil scored with his research on the topic "Programmable drug release from multi-unit granule systems".

"Our students are very creative and every year, thanks to the quality guidance of our university trainers and Zentiva experts, they create great works that have great potential to advance the pharmaceutical industry. During the 4 years of existence of The Parc, I already have 37 graduates who are remarkably successful and find employment both in the Czech Republic and abroad," explained Professor František Štěpánek, Scientific Director of The Parc.

Industrial PhDs are ongoing

The education provided within The Parc is an example of a so-called industrial doctorate, where part of the study takes place on campus under the supervision of university staff and part directly in an industrial setting. Therefore, it combines theoretical and practical education. "We are very happy that industrial PhDs are getting more attention in the Czech Republic. We have been promoting this idea for several years. In practice, we see that it is a very functional model. Part of the graduates find employment at Zentiva and thanks to With them, we are advancing our development of innovations so that we can bring more high-quality, affordable medicines to those who need them," said Pavel Šebek, Director of Research and Development at Zentiva.

There are currently 32 students and 34 supervisors involved in The Parc, of which 13 are academics and 21 are Zentiva experts. During the existence of the center, they have had more than 30 patents, more than 100 scientific publications and many prestigious awards. Start-up company MarbleMat, which was founded by one of Parc's graduates, was selected last year among the 20 most innovative start-ups for the InnoStars Awards 2022 competition.

About The Park

The Parc was founded by Zentiva with the contribution of the business and investment support agency Czech Invest and in cooperation with three academic partners: the Prague University of Chemistry and Technology, the Charles University Prague and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic. The Parc provides a world-class academic education combined with hands-on industrial and business experience under the guidance of academic and pharmaceutical industry experts. It allows students to obtain postgraduate training in pharmaceutical sciences related to chemistry, pharmaceutical technology, biopharmaceuticals and clinical research. Student research results are often explicitly implemented into real products that go to market and help real patients. In collaboration with academic partners across Europe, The Parc also offers student internships and research exchanges under the supervision of top scientists. More information about The Parc can be found at

About Zentiva

Zentiva is a producer of high-quality, affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,800 people and a network of manufacturing sites, including Prague, Bucharest and Ankleshwar, Zentiva strives to be the champion of branded and generic medicines in Europe to best support the daily healthcare needs of people. We believe that people need better access to high-quality, affordable medicines and healthcare more than ever. We work together with health professionals, pharmacies and authorities responsible for health systems to find solutions in the area of ​​reducing costs and improving access to medical care. More information can be found at

Photo - -

View original content: